Explore the revolutionary potential of precision medicine in this 58-minute World Economic Forum panel discussion. Delve into the challenges and opportunities presented by next-generation sequencing and CAR-T therapy as industry leaders address globalizing access, redesigning data governance, and navigating ethical complexities. Learn from experts representing the American Heart Association, Illumina, FDA, Novartis Pharma, and Singapore's Ministry of Health as they discuss topics such as data sharing, AI in healthcare, drug development, gene therapy, and equal access. Gain insights into the future of individualized treatments and their impact on healthcare systems worldwide.